Neos Therapeutics Inc (NEOS) Files 10-K for the Fiscal Year Ended on December 31, 2018
- By insider
Neos Therapeutics Inc (NEOS) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder using its drug delivery technologies. Neos Therapeutics Inc has a market cap of $133.132 million; its shares were traded at around $2.68 with and P/S ratio of 1.87.
Warning! GuruFocus has detected 1 Warning Sign with NEOS. Click here to check it out.
The intrinsic value of NEOS
For the last quarter Neos Therapeutics Inc reported a revenue of $15.4 million, compared with the revenue of $7.11 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $50.0 million, an increase of 99.8% from last year. For the last five years Neos Therapeutics Inc had an average revenue growth rate of 140.5% a year.
The reported loss per diluted share was $1.6 for the year, compared with the loss per share of $1.67 in the previous year. The Neos Therapeutics Inc had an operating margin of -87.01%, compared with the operating margin of -227.9% a year before. The 10-year historical median operating margin of Neos Therapeutics Inc is -834.67%. The profitability rank of the company is 4 (out of 10).
At the end of the fiscal year, Neos Therapeutics Inc has the cash and cash equivalents of $46.5 million, compared with $32.0 million in the previous year. The long term debt was $43.2 million, compared with $58.9 million in the previous year. Neos Therapeutics Inc has a financial strength rank of 3 (out of 10).
At the current stock price of $2.68, Neos Therapeutics Inc is traded at 81.6% discount to its historical median P/S valuation band of $14.54. The P/S ratio of the stock is 1.87, while the historical median P/S ratio is 10.16. The stock lost 70.22% during the past 12 months.
For the complete 20-year historical financial data of NEOS, click here.
This article first appeared on GuruFocus.
Warning! GuruFocus has detected 1 Warning Sign with NEOS. Click here to check it out.
The intrinsic value of NEOS
